Logo image of EXAS

EXACT SCIENCES CORP (EXAS) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:EXAS - US30063P1057 - Common Stock

102.11 USD
+0.33 (+0.32%)
Last: 1/9/2026, 8:00:01 PM
102.07 USD
-0.04 (-0.04%)
After Hours: 1/9/2026, 8:00:01 PM
Buy % Consensus

68

ChartMill assigns a Buy % Consensus number of 68% to EXAS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 100.65. This target is -1.43% below the current price.
EXAS was analyzed by 29 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about EXAS.
In the previous month the buy percentage consensus was at a similar level.
EXAS was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
EXAS Historical Analyst RatingsEXAS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -109 -99 -89 -79 -69 -59 -49 -39 -29 -19 -9 10 20 30

Price Target & Forecast

Price Low Median Mean High 102.1168.79107.10100.65110.25 - -32.63% 4.89% -1.43% 7.97%
EXAS Current Analyst RatingEXAS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2026-01-05 Evercore ISI Group Downgrade Outperform -> In-Line
2025-11-25 Canaccord Genuity Downgrade Buy -> Hold
2025-11-24 Benchmark Downgrade Buy -> Hold
2025-11-24 Jefferies Downgrade Buy -> Hold
2025-11-21 Guggenheim Downgrade Buy -> Neutral
2025-11-21 William Blair Downgrade Outperform -> Market Perform
2025-11-21 Barclays Downgrade Overweight -> Equal-Weight
2025-11-21 Wells Fargo Downgrade Overweight -> Equal-Weight
2025-11-20 BTIG Downgrade Buy -> Neutral
2025-11-11 Piper Sandler Maintains Overweight -> Overweight
2025-11-05 Wells Fargo Maintains Overweight -> Overweight
2025-11-04 TD Cowen Maintains Buy -> Buy
2025-11-04 Guggenheim Maintains Buy -> Buy
2025-11-04 BTIG Maintains Buy -> Buy
2025-11-04 Benchmark Maintains Buy -> Buy
2025-11-04 Stifel Maintains Buy -> Buy
2025-11-04 Barclays Maintains Overweight -> Overweight
2025-11-04 Baird Maintains Outperform -> Outperform
2025-10-22 BTIG Maintains Buy -> Buy
2025-10-08 Piper Sandler Maintains Overweight -> Overweight
2025-10-07 Evercore ISI Group Maintains Outperform -> Outperform
2025-10-02 Barclays Maintains Overweight -> Overweight
2025-09-11 Craig-Hallum Maintains Buy -> Buy
2025-08-12 BTIG Maintains Buy -> Buy
2025-08-11 Piper Sandler Maintains Overweight -> Overweight
2025-08-08 Evercore ISI Group Maintains Outperform -> Outperform
2025-08-07 UBS Maintains Neutral -> Neutral
2025-08-07 RBC Capital Maintains Sector Perform -> Sector Perform
2025-08-07 Barclays Maintains Overweight -> Overweight
2025-07-08 Evercore ISI Group Maintains Outperform -> Outperform

EXACT SCIENCES CORP / EXAS FAQ

What is the price target for EXAS stock?

29 analysts have analysed EXAS and the average price target is 100.65 USD. This implies a price decrease of -1.43% is expected in the next year compared to the current price of 102.11.


What is the consensus rating for EXACT SCIENCES CORP (EXAS) stock?

The consensus rating for EXACT SCIENCES CORP (EXAS) is 68.2759 / 100 . This indicates that analysts generally have a neutral outlook on the stock.